# Briviact

NDC: 50474-970
Generic name: brivaracetam
Labeler / Manufacturer: UCB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20160512

FDA application: NDA205837

## Active ingredients

- BRIVARACETAM: 50 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50474-970"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50474-970
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cf2f439-0e97-443e-8e33-25ecef616f6c